72 related articles for article (PubMed ID: 3382692)
1. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.
Banks JB; Wykle RL; O'Flaherty JT; Lumb RH
Biochim Biophys Acta; 1988 Jul; 961(1):48-52. PubMed ID: 3382692
[TBL] [Abstract][Full Text] [Related]
2. Binding of carbamyl-platelet-activating factor to the Raji lymphoblast platelet-activating factor receptor.
Travers JB; Li Q; Sprecher H; Fertel RH
Int J Immunopharmacol; 1992 May; 14(4):515-23. PubMed ID: 1325953
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
Snyder F
Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
[TBL] [Abstract][Full Text] [Related]
5. PAF-acether transfer activity in HL-60 cells is induced during differentiation.
Lumb RH; Record M; Ribbes G; Pool GL; Terce F; Chap H
Biochem Biophys Res Commun; 1990 Sep; 171(2):548-54. PubMed ID: 2169726
[TBL] [Abstract][Full Text] [Related]
6. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the enzymatic hydrolysis of acetate from alkylacetylglycerols in the de novo pathway of PAF biosynthesis.
Blank ML; Smith ZL; Cress EA; Snyder F
Biochim Biophys Acta; 1990 Feb; 1042(2):153-8. PubMed ID: 2302414
[TBL] [Abstract][Full Text] [Related]
8. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
9. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.
Snyder F
Am J Physiol; 1990 Nov; 259(5 Pt 1):C697-708. PubMed ID: 2240190
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
13. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
14. Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.
Albert DH; Snyder F
Biochim Biophys Acta; 1984 Oct; 796(1):92-101. PubMed ID: 6435681
[TBL] [Abstract][Full Text] [Related]
15. Exogenously added alkylmethylglycerophosphocholine and alkylmethylcarbamylglycerophosphocholine accumulate in plasma membranes more than in intracellular membranes of rabbit platelets.
Tokumura A; Tsutsumi T; Nishioka Y; Tsukatani H
Chem Phys Lipids; 1997 Mar; 86(1):75-83. PubMed ID: 9149390
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
17. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
18. Non-enzymatic platelet-activating factor formation by acetylated proteins.
Thanou PG; Tsoukatos DC
FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide.
Karasawa K; Qiu X; Lee T
J Biol Chem; 1999 Mar; 274(13):8655-61. PubMed ID: 10085103
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]